Direct antiviral agents against hepatitis C virus: Beneficial or harmful?

被引：0
|
作者：
Murcia, Oscar [1 ]
Carnicer, Fernando [1 ]
Gomez-Escolar, Laura [2 ]
Miralles, Cayetano [3 ]
Pilar Grino, Maria [4 ]
Barquero Martin, Claudia [5 ]
Pascual, Sonia [1 ]
机构：
[1] Hosp Gen Univ Alicante, Dept Hepatol, Alicante, Spain
[2] Hosp Marina Baixa, Dept Hepatol, Villajoyosa, Spain
[3] Hosp Vinalopo, Dept Hepatol, Elche, Spain
[4] Hosp San Juan Alicante, Dept Hepatol, Alicante, Spain
[5] Hosp Gen Torrevieja, Dept Hepatol, Alicante, Spain
来源：
JOURNAL OF HEPATOLOGY | 2018年 / 68卷 / 04期
关键词：
INTERFERON-FREE THERAPY; EARLY TUMOR RECURRENCE; HEPATOCELLULAR-CARCINOMA; HCC; RISK;
D O I：
10.1016/j.jhep.2017.10.026
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：844 / 845
页数：2
相关论文
共 50 条
  • [41] Occurrence of hepatocellular carcinoma after direct-acting antiviral therapy for hepatitis C virus infection: literature review and risk analysis
    Galati, Giovanni
    Muley, Moises
    Vigano, Mauro
    Iavarone, Massimo
    Vitale, Alessandro
    Dell'Unto, Chiara
    Lai, Quirino
    Cabibbo, Giuseppe
    Sacco, Rodolfo
    Villa, Erica
    Trevisani, Franco
    EXPERT OPINION ON DRUG SAFETY, 2019, 18 (07) : 603 - 610
  • [42] Serum Angiopoietin-2 Levels Predict the Development of Hepatocellular Carcinoma following Hepatitis C Virus Eradication Using Direct-Acting Antiviral Agents
    Suzuki, Takanori
    Matsuura, Kentaro
    Nagura, Yoshihito
    Kawamura, Hayato
    Fujiwara, Kei
    Ogawa, Shintaro
    Nagaoka, Katsuya
    Iio, Etsuko
    Watanabe, Takehisa
    Kataoka, Hiromi
    Tanaka, Yasuhito
    ONCOLOGY, 2024, 102 (07) : 611 - 620
  • [43] Hepatitis C virus eradication with direct-acting antiviral improves insulin resistance
    Russo, Francesco Paolo
    Zanetto, Alberto
    Gambato, Martina
    Bortoluzzi, Ilaria
    Al Zoairy, Ramona
    Franceschet, Enrica
    De Marchi, Federica
    Marzi, Luca
    Lynch, Erica Nicola
    Floreani, Annarosa
    Farinati, Fabio
    Schaefer, Benedikt
    Burra, Patrizia
    Zoller, Heinz
    Mega, Andrea
    JOURNAL OF VIRAL HEPATITIS, 2020, 27 (02) : 188 - 194
  • [44] What Are the Benefits of a Sustained Virologic Response to Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection?
    Ioannou, George N.
    Feld, Jordan J.
    GASTROENTEROLOGY, 2019, 156 (02) : 446 - +
  • [45] Direct antiviral agents for chronic hepatitis C virus infection improve health-related quality of life significantly in the long term
    Atamla, Mahmoud
    Khoury, Johad
    Dabbah, Ihab
    Kramsky, Rimma
    Yaacob, Afif
    Veitsman, Ella
    Saadi, Tarek
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2021, 7 (03) : 258 - 263
  • [46] Association between direct-acting antiviral agents in hepatitis C virus treatment and hepatocellular carcinoma occurrence and recurrence: The endless debate
    Kamal, Ahmed
    Elsheaita, Ahmed
    Abdelnabi, Mahmoud
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (06) : 1764 - 1774
  • [47] Impact of direct antiviral agents for hepatitis C virus -induced liver diseases on registration, waiting list and liver transplant activity in France
    Coilly, Audrey
    Jasseron, Carine
    Legeai, Camille
    Conti, Filomena
    Duvoux, Christophe
    Kamar, Nassim
    Dharancy, Sebastien
    Antoine, Corinne
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2023, 47 (08)
  • [48] Hepatitis C and hepatitis B virus infection in hemodialysis patients after nationwide direct antiviral agents therapy-experience of 10 Romanian HD centers
    Marc, Luciana
    Mihaescu, Adelina
    Lupusoru, Raluca
    Schiller, Oana
    Bob, Flaviu
    Chisavu, Lazar
    Bende, Felix
    Sirli, Roxana
    Schiller, Adalbert
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2023, 55 (11) : 2951 - 2958
  • [49] The Impact of Antiviral Therapy for Hepatitis C Virus on the Survival of Patients after Hepatocellular Carcinoma Treatment
    Mori, Yuki
    Matsuda, Shuya
    Sato, Mitsuaki
    Muraoka, Masaru
    Suzuki, Yuichiro
    Tatsumi, Akihisa
    Nakayama, Yasuhiro
    Inoue, Taisuke
    Maekawa, Shinya
    Enomoto, Nobuyuki
    INTERNAL MEDICINE, 2022, 61 (18) : 2721 - 2729
  • [50] Fibrosis Regression Post Direct-acting Antiviral Treatment in Hepatitis C Virus Patients
    Demir, Nurhan
    Gulluoglu, Alper
    MEDICAL JOURNAL OF BAKIRKOY, 2023, 19 (01) : 15 - 21
12345